No abstract available
Keywords:
car-t; follow-up; malignancies; second cancer; therapy.
MeSH terms
-
Humans
-
Immunotherapy, Adoptive* / adverse effects
-
Immunotherapy, Adoptive* / methods
-
Neoplasms, Second Primary* / etiology
-
Receptors, Chimeric Antigen* / immunology
-
Treatment Outcome
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.